🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Galen called it “The Great Nerve” with good reason. buff.ly/7AYmcdb

RIP Livia Fränkl בָּרוּךְ דַּיַּן הָאֱמֶת

👇🏼

🧠 Frailty matters in kidney transplantation! By Helen Erlandsson 🔍 Pre-KTx sarcopenia assessment helps predict outcomes & optimize care. 💪 Tools: DEXA/BIA muscle mass, grip strength, gait speed. #KidneyTransplant #Sarcopenia #Frailty #ERA25 #NephTwitter

Can not imagine better #ERA25 beginning with GN CME course chaired by Annette Bruchfeld Andreas Kronbichler ERA - European Renal Association #BeyondNephrology

Happy to see that ‘our’ content is much appreciated by the audience #ERA25! True innovation with focus on nephrology happens in the GN space! Drugs developed primarily in renal indications!

Our review on advances in the treatment of AAV is out now in NatRevRheumatol. It provides an update on currently used therapies and identified major innovations which will become relevant in the next couple of years! EUVAS nature.com/articles/s4158…

Nomenclature alert 📢 Disease-modifying anti-nephropathic drugs (DMANDs): a definition proposed by the Immunonephrology Working Group (IWG) of ERA - European Renal Association #ERA25 🇦🇹 #Nephpearls #IgAN 📌 This is an important topic of discussion particularly because of the advent of several

Prediction modelling in #ANCA #Vasculitis to improve patient education, shared decision-making and therapeutic evaluation, thanks to ERA - European Renal Association and Annette Bruchfeld for highlighting the importance of prognostic tools in optimising patient care at #ERA25 👏👏👏

“This is why I value that little phrase “I don’t know” so highly. It’s small, but it flies on mighty wings.” - Literature laureate Wislawa Szymborska on the importance of telling oneself “I don't know.”

Do you have crescentic IgA Nephropathy? You may qualify for a Mayo Clinic clinical trial evaluating a novel treatment for crescentic IgAN. “Avacopan in Crescentic IgAN” Learn more and see if you are eligible: Link 🔗 mayo.edu/research/clini… fernando fervenza Ladan Zand

🤩 Great summary of Late Breaking Clinical trials and relevand studies presented during #ERA25 ERA - European Renal Association ✨Fab panelists lineup Roser Torra Dr Dr Kate Stevens💙 Lonnie Pyne Natalie Staplin Jonathan Barratt 👏markusathome youtu.be/HbUEh8oLB2M?si…

Ongoing discussion about UACR or UPCR in glomerulonephritis captured by NDT Albuminuria predicts kidney events in IgAN academic.oup.com/ndt/article/40…

Thank you Hans-Joachim Anders

🫘Pillars of care in CKD academic.oup.com/ndt/article/40… NDT Hans-Joachim Anders

🌟Today's "Members' Stories" features Andreas Kronbichler, Winner of the 2024 ERA Eberhard Ritz Award for Young Investigators in Clinical Science. 🏆 Andreas shares the impact of ERA Awards: strengthening global collaborations and future contributions in nephrology. 📖 Read more

Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors: A Systematic Review and Individual Participant Data Meta-Analysis | Surgery | JAMA Oncology | JAMA Network jamanetwork.com/journals/jamao…

IL-7Ra signalling in AAV links to relapse/resistance Our recent paper 🔹defined activated & exhausted T cells in experimental AAV kidneys 🔹neutralised IL-7Ra - a non-depleting mAb - to limit ANCA-associated GN Similar mAbs are in Phase 2 clinical trials academic.oup.com/ndt/article-ab…

It was a pleasure to collaborate with Andreas Kronbichler and Astrid Weins on this article. We describe transformations in our understanding of podocytopathies, and novel treatment approaches in light of those advancements. journals.lww.com/co-nephrolhype…

Urinary rituximab loss and rate of treatment failure in membranous nephropathy doi.org/10.1093/ndt/gf…